Galectin-10, eosinophils, and celiac disease

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 357-364

  De Re, Valli ^c   Simula, Maria Paola ^a   Cannizzaro, Renato ^b   Pavan, Alessandro ^a   De Zorzi, Mari Angela ^a   Toffoli, Giuseppe ^a   Canzonieri, Vincenzo ^c  

^a Experimental and Clinical Pharmacology Unit

^b Gastroenterology

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

2D DIGE; Celiac disease; Charcot Leyden; Eosinophil; Galectin 10

Indexed keywords

GALECTIN; GALECTIN 10; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGENIC VARIATION; CELIAC DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DUODENUM BIOPSY; EOSINOPHIL; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; INTESTINE BIOPSY; PROTEIN EXPRESSION; SCORING SYSTEM; TWO DIMENSIONAL ELECTROPHORESIS;

TRITICUM AESTIVUM;

EID: 69949123793     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04627.x     Document Type: Conference Paper

References (43)

1. Green, P.H. & C. Cellier. 2007. Celiac disease. N. Engl. J. Med. 357: 1731-1743.
2. Briani, C., D. Samaroo & A. Alaedini. 2008. Celiac disease: from gluten to autoimmunity. Autoimmun. Rev. 7: 644-650.
3. Shaoul, R. & A. Lerner 2007. Associated autoanti-bodies in celiac disease. Autoimmun. Rev. 6: 559-565.
4. Neuhausen, S.L. et al. 2008. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J. Autoimmun. 31: 160-165.
5. Bagnasco, M., L. Grassia & G. Pesce. 2007. The management of the patient with unexpected autoan-tibody positivity. Autoimmun. Rev. 6: 347-353.
6. Tommasini, A. et al. 2004. Mass screening for coeliac disease using anti-human transglutaminase antibody assay. Arch. Dis. Child. 89: 512-515.
7. Freitag, T. et al. 2004. The role of the immune response against tissue transglutaminase in the patho-genesis of coeliac disease. Autoimmun. Rev. 3: 13-20.
8. Reif, S. & A. Lerner. 2004. Tissue transglutaminase-the key player in celiac disease: a review. Autoimmun. Rev. 3: 40-45.
9. Oberhuber, G. et al. 1999. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol. 11: 1185-1194.
10. De Re, V. et al. 2007. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig. Liver. Dis. 39: S65-S71.
11. De Re, V. et al. 2007. Proteins specifically hyperex-pressed in a coeliac disease patient with aberrant T cells. Clin. Exp. Immunol. 148: 402-409.
12. De Re, V. et al. 2008. HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa. Proteomics-Clinical Applications 9: 1290-1299.
13. De Re, V. et al. 2006. Type II. mixed cryoglobuli-naemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology 45: 685-693.
14. Foell, J.L. et al. 2008. Loss of detectability of Charcot-Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide. J. Immunol. Methods 339: 99-103.
15. Sampson, H.A. 1999. Food allergy. Part 1: im-munopathogenesis and clinical disorders. J. Allergy Clin. Immunol. 103: 717-728.
16. Hogan, S.P. et al. 2008. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy 38: 709-750.
17. Hogan, S.P. & M.E. Rothenberg. 2006. Eosinophil function in eosinophil-associated gastrointestinal disorders. Curr. Allergy Asthma Rep. 6: 65-71.
18. Wedemeyer, J. & K. Vosskuhl. 2008. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours. Best Pract. Res. Clin. Gastroen-terol. 22: 537-549.
19. Plot, L. & H. Amital. 2008. Infectious associations of Celiac disease. Autoimmun. Rev. [Epub ahead of print.] doi: 10.1016/j.autrev.2008.10. 001.
20. Fjaerli, H.O. et al. 2006. Whole blood gene expression in infants with respiratory syncytial virus bronchioli-tis. BMC Infect. Dis. 6: 175.
21. Fjaeri, H. et al. 2006. Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect. Dis. 6: 175-182.
22. Ghafouri, B.K. et al. 2006. Comparative proteomics of nasal fluid in seasonal allergic rhinitis. J. Proteome Res. 5: 330-338.
23. Devouassoux, G. et al. 2008. Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma. Allergy 63: 125-131.
24. Liu, F.T. & G.A. Rabinovich. 2005. Galectins as modulators of tumour progression. Nat. Rev. Cancer 5: 29-41.
25. Trulson, A. et al. 1997. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br. J. Haematol. 98: 312-314.
26. Aydin, O. 2006. Charcot-Leyden crystals in a pro-static adenocarcinoma. Diagn. Pathol. 1: 26.
27. Dvorak, A.M. et al. 1990. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospho-lipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas. Lab. Invest. 62: 608-615.
28. Axdorph, U. et al. 2001. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease. Leuk. Lymphoma 42: 1055-1065.
29. Caruso, R.A. et al. 2005. Degranulation patterns of eosinophils in advanced gastric carcinoma: an electron microscopic study. Ultrastruct. Pathol. 29: 29-36.
30. Lotfi, R. et al. 2007. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J. Immunother. 30: 16-28.
31. Shunyakov, L. et al. 2004. The influence of host response on colorectal cancer prognosis. Clin. Colorectal Cancer 4: 38-45.
32. Samoszuk, M. 1997. Eosinophils and human cancer. Histol. Histopathol. 12: 807-812.
33. Liu, L.Y. et al. 2007. Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J. Immunol. 179: 4840-4848.
34. Spencer, L.A. et al. 2008. Human eosinophils consti-tutively express multiple Th1, Th2, and immunoreg-ulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. [Epub ahead of print.]
35. Shi, H.Z. 2004. Eosinophils function as antigen-presenting cells. J. Leukoc. Biol. 76: 520-527.
36. Furuta, G.T. et al. 1995. The role of the eosinophil in gastrointestinal diseases. Curr. Opin. Gastroenterol. 11: 541-547.
37. Noel, R.J. et al. 2004. Clinical and immunopatho-logic effects of swallowed fluticasone for eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 2: 568-575.
38. Forbes, E. et al. 2008. IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hy-persensitivity. J. Exp. Med. 205: 897-913.
39. Forbes E. et al. 2006. ICAM-1-dependent pathways regulate colonic eosinophilic inflammation. J. Leukoc. Biol. 80: 330-341.
40. Hogan S.P. et al. 2002. Experimental analysis of eosinophil-associated gastrointestinal diseases. Curr. Opin. Allergy. Clin. Immunol. 2: 239-248.
41. Rothenberg, M.E. & S.P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
42. Rothenberg, M.E. et al. 2001. Gastrointestinal eosinophils. Immunol. Rev. 179: 139-155.
43. Simon, P. et al. 2000. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc. Natl. Acad. Sci. USA 97: 6681-6686.